Paychex (PAYX) director gets 725 RSUs, 3,061 options grant

Paychex (PAYX) reported an insider equity award on Form 4.

Rhea-AI Filing Summary

Paychex (PAYX) reported an insider equity award on Form 4. A director acquired 725 shares of common stock via restricted stock units on 10/15/2025 at $0, increasing beneficial ownership to 79,344 shares directly.

The filing also shows a new stock option grant for 3,061 shares at an exercise price of $127.52 on 10/15/2025, first exercisable on 10/15/2026 and expiring on 10/14/2035. Existing option holdings remain outstanding across multiple grants, with exercise prices ranging from $57.20 to $140.68 and expirations extending through 2035. The RSU award is pursuant to the Amended and Restated 2002 Stock Incentive Plan.

Insider Trade Summary

Grant/Award: 3,786 shares

Grant/Award 12 txns

Insider VELLI JOSEPH M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	3,061	$127.52	$390K
Grant/Award	Common Stock	725	$0.00	$0.00
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--

Holdings After Transaction: Stock Option — 60,764 contracts for 57,703 underlying shares (Direct); Common Stock — 79,344 shares (Direct)

Footnotes (1)

1. F1. Award of restricted stock units, subject to vesting, pursuant to the Amended and Restated 2002 Stock Incentive Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did PAYX disclose in this Form 4?

A director reported receiving 725 RSUs on 10/15/2025 at $0 and a new stock option grant for 3,061 shares at $127.52.

How many PAYX shares does the reporting person own after the transaction?

Beneficial ownership is 79,344 shares directly following the reported transactions.

What are the terms of the new PAYX stock option grant?

Options for 3,061 shares at $127.52, first exercisable on 10/15/2026, expiring on 10/14/2035.

Was the PAYX equity award part of a stock plan?

Yes. The 725 RSUs were awarded pursuant to the Amended and Restated 2002 Stock Incentive Plan.

What other PAYX options are outstanding for the insider?

Multiple grants remain outstanding, with exercise prices from $57.20 to $140.68 and expirations through 2035.

What is the insider’s role at PAYX?

The reporting person is a Director of Paychex, Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/17/2025 - 04:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VELLI JOSEPH M

(Last) (First) (Middle)

911 PANORAMA TRAIL SOUTH

(Street)

ROCHESTER NY 14625

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PAYCHEX INC [ PAYX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/15/2025		A		725(1)	A	$0	79,344	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$127.52	10/15/2025		A		3,061		10/15/2026	10/14/2035	Common Stock	3,061	$127.52	3,061	D
Stock Option	$60.59							07/07/2017	07/06/2026	Common Stock	10,220		10,220	D
Stock Option	$57.2							07/13/2018	07/12/2027	Common Stock	9,615		9,615	D
Stock Option	$70.37							07/12/2019	07/11/2028	Common Stock	8,641		8,641	D
Stock Option	$85.33							07/11/2020	07/10/2029	Common Stock	7,929		7,929	D
Stock Option	$73.53							07/15/2021	07/14/2030	Common Stock	5,793		5,793	D
Stock Option	$112.67							07/15/2022	07/14/2031	Common Stock	5,075		5,075	D
Stock Option	$115							07/15/2023	07/14/2032	Common Stock	3,027		3,027	D
Stock Option	$120.86							07/15/2024	07/14/2033	Common Stock	3,382		3,382	D
Stock Option	$121.63							07/15/2025	07/14/2034	Common Stock	3,351		3,351	D
Stock Option	$140.68							07/15/2026	07/14/2035	Common Stock	670		670	D

Explanation of Responses:

1. Award of restricted stock units, subject to vesting, pursuant to the Amended and Restated 2002 Stock Incentive Plan.

	Prabha S. Bhandari, Attorney-in-fact	10/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.